Fate Therapeutics Inc. buy Piper Sandler
Start price
17.06.24
/
50%
€3.65
Target price
17.06.25
€5.60
Performance (%)
-16.68%
Price
01.10.24
€3.04
Summary
This prediction is currently active. The price of Fate Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.68%. This prediction currently runs until 17.06.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Fate Therapeutics Inc. | -1.935% | -1.935% |
iShares Core DAX® | 1.164% | 1.549% |
iShares Nasdaq 100 | 0.118% | 0.969% |
iShares Nikkei 225® | 1.124% | -1.120% |
iShares S&P 500 | 0.479% | 1.068% |
Comments by Piper_Sandler for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $6.00 price target on the stock, up previously from $4.00.
Ratings data for FATE provided by MarketBeat